Denali Therapeutics (DNLI) Insider Trading & Ownership

$30.32

+0.08 (+0.26%)

(As of 09/24/2024 ET)

Current Insider Ownership Percentage: 7.90%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $3.90 M

Get DNLI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Denali Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DNLI Insider Buying and Selling by Quarter

Ad Porter & Company

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

Denali Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/1/2024	Steve E Krognes	Director	Sell	30,000	$22.12	$663,600.00
6/13/2024	Steve E Krognes	Director	Sell	688	$21.79	$14,991.52
6/6/2024	Jennifer E Cook	Director	Sell	1,458	$21.73	$31,682.34
4/15/2024	Vicki L Sato	Director	Sell	1,666	$18.29	$30,471.14
4/1/2024	Steve E Krognes	Director	Sell	92,500	$20.50	$1,896,250.00
2/15/2024	Vicki L Sato	Director	Sell	1,666	$18.37	$30,604.42
Kamala’s tax plan is worse than you think—find out why (Ad) Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention. Get your FREE, no-obligation Wealth Protection Guide now
2/13/2024	Carole Ho	Insider	Sell	2,784	$17.29	$48,135.36
2/13/2024	Ryan J Watts	CEO	Sell	9,589	$17.29	$165,793.81
2/13/2024	Steve E Krognes	Director	Sell	2,750	$17.29	$47,547.50
1/16/2024	Vicki L Sato	Director	Sell	1,666	$18.42	$30,687.72
1/10/2024	Carole Ho	Insider	Sell	4,668	$19.02	$88,785.36
1/9/2024	Ryan J Watts	CEO	Sell	7,818	$19.78	$154,640.04
1/5/2024	Carole Ho	Insider	Sell	9,972	$19.43	$193,755.96
1/5/2024	Ryan J Watts	CEO	Sell	17,483	$19.43	$339,694.69
1/5/2024	Steve E Krognes	Director	Sell	3,208	$19.43	$62,331.44
12/15/2023	Vicki L Sato	Director	Sell	1,666	$23.39	$38,967.74
11/15/2023	Vicki L Sato	Director	Sell	1,666	$19.13	$31,870.58
10/16/2023	Vicki L Sato	Director	Sell	1,666	$20.66	$34,419.56

(Data available from 1/1/2013 forward)

DNLI Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Denali Therapeutics includes Alexander O Schuth, Carole Ho, Jennifer E Cook, Marc Tessier-Lavigne, Ryan J Watts, Steve E Krognes, and Vicki L Sato. Learn more on insiders at DNLI.
: 7.90% of Denali Therapeutics stock is owned by insiders. Learn more on DNLI's insider holdings.
: The following insiders have sold DNLI shares in the last 24 months: Alexander O Schuth ($1,005,054.08), Carole Ho ($950,856.53), Jennifer E Cook ($31,682.34), Marc Tessier-Lavigne ($1,490,189.60), Ryan J Watts ($2,721,813.31), Steve E Krognes ($2,939,629.72), and Vicki L Sato ($375,882.92).
: Insiders have sold a total of 387,733 Denali Therapeutics shares in the last 24 months for a total of $9,515,108.50 sold.

Denali Therapeutics Key Executives

Dr. Ryan J. Watts Ph.D. (Age 48)
Co-Founder, President, CEO & Director
Compensation: $1.15M
Dr. Alexander O. Schuth M.D. (Age 51)
Co-Founder, CFO, COO & Secretary
Compensation: $802.29k
Dr. Marc Tessier-Lavigne Ph.D. (Age 64)
Co-Founder & Independent Director
Compensation: $57.5k
Dr. Carole Ho M.D. (Age 51)
Chief Medical Officer & Head of Development
Compensation: $802.29k
Mr. Tyler M. Nielsen (Age 46)
Senior Vice President of Corporate Finance
Dr. Dana Andersen
Chief Technical and Manufacturing Officer
Mr. Joe Lewcock Ph.D.
Chief Scientific Officer
Dr. Laura Hansen
Vice President of Investor Relations
Mr. Chris Walsh
General Counsel
Mr. Mark Rowen
Vice President of Corporate Development